These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

178 related items for PubMed ID: 19764697

  • 1. Neuroleptic malignant syndrome without withdrawal of levodopa.
    Singla R, Singla A, Kumar S, Kar P.
    Natl Med J India; 2009; 22(3):162. PubMed ID: 19764697
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
    Keyser DL, Rodnitzky RL.
    Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Successful treatment of levodopa-induced myoclonus and levodopa withdrawal-induced neuroleptic malignant syndrome. A case report.
    Hirschorn KA, Greenberg HS.
    Clin Neuropharmacol; 1988 Jun; 11(3):278-81. PubMed ID: 3401861
    [No Abstract] [Full Text] [Related]

  • 6. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC, Chew EL, Ong YY.
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. A neuroleptic malignantlike syndrome due to levodopa therapy withdrawal.
    Friedman JH, Feinberg SS, Feldman RG.
    JAMA; 1985 Nov 15; 254(19):2792-5. PubMed ID: 4057489
    [Abstract] [Full Text] [Related]

  • 9. Neuroleptic malignant syndrome in a parkinsonian woman during the premenstrual period.
    Mizuta E, Yamasaki S, Nakatake M, Kuno S.
    Neurology; 1993 May 15; 43(5):1048-9. PubMed ID: 7605396
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Neuroleptic malignant like syndrome in two patients on cholinesterase inhibitors.
    Grace JB, Thompson P.
    Int J Geriatr Psychiatry; 2006 Feb 15; 21(2):193-4. PubMed ID: 16440373
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Apomorphine in malignant syndrome due to levodopa withdrawal.
    Bonuccelli U, Piccini P, Corsini GU, Muratorio A.
    Ital J Neurol Sci; 1992 Mar 15; 13(2):169-70. PubMed ID: 1592579
    [Abstract] [Full Text] [Related]

  • 16. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
    Rainer C, Scheinost NA, Lefeber EJ.
    Postgrad Med; 1991 Apr 15; 89(5):175-8, 180. PubMed ID: 2008397
    [Abstract] [Full Text] [Related]

  • 17. [Prevention and treatment of malignant syndrome in patients with Parkinson's disease].
    Kuno S.
    Nihon Rinsho; 2004 Sep 15; 62(9):1721-4. PubMed ID: 15462391
    [Abstract] [Full Text] [Related]

  • 18. A case of malignant syndrome associated with a parkinsonism patient.
    Sanga M, Nomura S.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2003 Apr 15; 23(2):91-5. PubMed ID: 12762221
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Neuroleptic malignant-like syndrome: case report.
    Tibbels CK, Seegers S.
    Tex Med; 1988 May 15; 84(5):40-3. PubMed ID: 3406898
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.